TEKMIRA PHARMACEUTICALS CORPORATION Inactive Instrument
Sector Chart Tekmira Pharmaceuticals Corporation Toronto S.E.
Equities
TKM
CA87911B2093
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 94.22B | ||||||
| 37.76B | ||||||
| 32.5B | ||||||
| 27.75B | ||||||
| 16.13B |
